Worrying Surge of BTMPS in Fentanyl Supply
There's been a troubling development with the discovery of an industrial chemical known as bis (2,2,6,6-tetramethyl-4-piperidyl) sebacate, or BTMPS, in illicit fentanyl across the United States. Originally used in plastics to protect against UV rays, the presence of BTMPS in fentanyl raises major health concerns.
Thousands Potentially at Risk
Recent studies from UCLA and other institutions reveal that nearly 25% of drug samples marketed as fentanyl contain BTMPS. This sharp rise marks one of the most significant changes in the drug supply, hinting at a potential crisis for users.
Disturbing Numbers in Los Angeles
In Los Angeles, the occurrence of BTMPS-laced fentanyl skyrocketed from zero cases in June to an alarming 41% by August. This shocking statistic highlights the risk of widespread exposure, putting tens of thousands of individuals in danger due to this significant increase.
Insights from Experts on the BTMPS Crisis
Chelsea Shover, an assistant professor at UCLA, points out that drug producers may be adding BTMPS to their products to improve their stability against degradation from light and heat. This reflects a troubling adaptability in the illegal drug market.
Examining the War on Drugs
Nicolas Tentoni, a pharmacology expert from the University of Buenos Aires, links the rise in dangerous additives like BTMPS to the overall failures in the War on Drugs. He believes that the illegal drug market's move toward hazardous additives is a result of criminalizing drug use, which forces the trade underground.
Health Risks Associated with BTMPS
The toxicological profile of BTMPS is concerning. It affects calcium channels and inhibits certain receptors, possibly leading to serious cardiovascular issues. These health dangers, combined with the already perilous nature of substances like fentanyl, make it urgent to address the issue of contaminated drug supplies.
The Value of Drug Testing Programs
Expanded drug testing initiatives in certain areas have proven effective in helping users make informed decisions. By enabling individuals to detect harmful adulterants, these programs can significantly minimize the health risks linked to drug use.
Hurdles in Detection and Need for Policy Changes
At present, the lack of rapid test strips for BTMPS is a major obstacle. Unlike fentanyl, there aren’t any routine screenings for BTMPS, leaving many users unaware of the potential hazards. As the drug landscape becomes increasingly dangerous, addressing the gaps in drug policies is essential.
Critical Call for Comprehensive Harm Reduction
As we contend with a more perilous drug environment, there's an urgent need for comprehensive harm reduction strategies, including safe supply initiatives. The rising presence of harmful substances highlights the necessity for innovative approaches to safeguard user safety.
Frequently Asked Questions
What is BTMPS and why should people be worried?
BTMPS is an industrial chemical that has recently been discovered in fentanyl, raising serious health concerns because of its potential harmful effects.
How can BTMPS impact health?
BTMPS can affect calcium channels and inhibit certain receptors, potentially leading to severe cardiovascular complications.
What has caused the rise in BTMPS detection?
The detection of BTMPS in fentanyl has increased due to shifts in drug manufacturing methods aimed at improving product stability.
What is the role of drug testing programs?
Drug testing programs help users identify harmful substances within drugs, encouraging safer consumption habits.
What changes are needed in drug policy?
There's a significant need for reforms that tackle the root causes of drug prohibition and promote harm reduction policies.
